Compare MSBI & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MSBI | BIOA |
|---|---|---|
| Founded | 1881 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 456.2M | 443.9M |
| IPO Year | 2016 | 2024 |
| Metric | MSBI | BIOA |
|---|---|---|
| Price | $23.89 | $19.52 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 4 |
| Target Price | $22.83 | ★ $33.33 |
| AVG Volume (30 Days) | 186.4K | ★ 1.0M |
| Earning Date | 01-22-2026 | 03-19-2026 |
| Dividend Yield | ★ 5.41% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $210,718,000.00 | $5,917,000.00 |
| Revenue This Year | $28.14 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $14.24 | $2.88 |
| 52 Week High | $24.57 | $24.00 |
| Indicator | MSBI | BIOA |
|---|---|---|
| Relative Strength Index (RSI) | 71.15 | 58.94 |
| Support Level | $22.43 | $18.70 |
| Resistance Level | $23.22 | $20.66 |
| Average True Range (ATR) | 0.72 | 1.43 |
| MACD | -0.02 | -0.26 |
| Stochastic Oscillator | 81.79 | 22.76 |
Midland States Bancorp Inc is a diversified financial holding company. The company provides a full range of commercial and consumer banking products and services, business equipment financing, merchant credit card services, trust and investment management, and insurance and financial planning services. The Banking segment, which generates the majority of the revenue, provides financial products and services to consumers and businesses, including commercial, commercial real estate, mortgage, and other consumer loan products; commercial equipment financing, etc. The Wealth Management segment consists of trust and fiduciary services, brokerage, and retirement planning services. The Corporate segment includes the holding company's financing and investment activities, administrative expenses.
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.